← All stocks

CORCEPT THERAPEUTICS INC

CORT Net selling
CIK 0001088856 #827 in the set updated 17 Sep 2026
Bought (12 mo)
$3.31M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$102.49M
$29.98M on a plan · $68.79M straight out of an exercise
Sold at will
$3.72M
5 of 108 sales
Net
−$99.17M
−$404.15K against sales at will

By person

14 insiders · 120 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Maduck Sean
See Remarks
$23.27M (20) scheduled
−$23.27M
53,938
0.0499%
$6.03M
+37.0%
Mokari Atabak
Chief Financial Officer
$18.73M (22) scheduled
−$18.73M
16,304
0.0151%
$1.82M
+30.2%
Guyer William
Chief Development Officer
$14.91M (19) scheduled
−$14.91M
4,313
0.0040%
$481.78K
−25.6%
MAHONEY DAVID L
Director
$13.94M (5) scheduled
−$13.94M
1,133,539
1.05%
$126.62M
−8.0%
BELANOFF JOSEPH K
Chief Executive Officer
$13.79M (11) scheduled
−$13.79M
2,565,489
2.37%
$286.58M
−5.8%
Vieira Roberto Wandenkolk
President, Oncology
$6.46M (7) scheduled
−$6.46M
4,242
0.0039%
$473.85K
+4.3%
WILSON JAMES N
Director
$3.94M (12) scheduled
−$3.94M
2,539,086
2.35%
$283.63M
−22.8%
BAKER G LEONARD JR
Director
$3.31M (2)
+$3.31M
2,241,893
2.07%
$250.43M
+12.0%
Park Kimberly
Director
$3.27M (1) scheduled
−$3.27M
0
0.0000%
$0.00
Lyon Joseph Douglas
See Remarks
$2.83M (9) scheduled
−$2.83M
5,683
0.0053%
$634.81K
−42.6%
Robb Gary Charles
Chief Business Officer
$1.16M (1)
−$1.16M
108,666
0.1005%
$12.14M
+47.2%
Swisher Daniel N JR
Director
$192.59K (1) scheduled
−$192.59K
0
0.0000%
$0.00
Hunt Hazel
Chief Scientific Officer
255,437
0.2363%
$28.53M
+115.4%
Cannon Gillian
Director
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
WILSON JAMES N
15 Sep 2026
Director
Sold on a plan indirect
2,800
$111.70
$312.77K
WILSON JAMES N
15 Sep 2026
Director
Sold on a plan indirect
400
$110.84
$44.33K
WILSON JAMES N
15 Sep 2026
Director
Sold on a plan indirect
6,800
$110.27
$749.83K
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
400
$119.64
$47.86K
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
7,055
$118.88
$838.71K
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
91,167
$118.24
$10.78M
MAHONEY DAVID L
18 Aug 2026
Director
Sold on a plan indirect
4,984
$117.47
$585.48K
WILSON JAMES N
14 Aug 2026
Director
Sold on a plan indirect
2,279
$112.64
$256.71K
WILSON JAMES N
14 Aug 2026
Director
Sold on a plan indirect
4,668
$111.44
$520.21K
WILSON JAMES N
14 Aug 2026
Director
Sold on a plan indirect
3,053
$110.49
$337.34K
WILSON JAMES N
15 Jul 2026
Director
Sold on a plan indirect
1,978
$89.49
$177.01K
WILSON JAMES N
15 Jul 2026
Director
Sold on a plan indirect
2,974
$88.81
$264.12K
WILSON JAMES N
15 Jul 2026
Director
Sold on a plan indirect
3,969
$87.74
$348.22K
WILSON JAMES N
15 Jul 2026
Director
Sold on a plan indirect
1,079
$86.78
$93.63K
WILSON JAMES N
16 Jun 2026
Director
Sold on a plan indirect
5,823
$83.57
$486.63K
WILSON JAMES N
16 Jun 2026
Director
Sold on a plan indirect
4,177
$82.69
$345.42K
BELANOFF JOSEPH K
1 Jun 2026
Chief Executive Officer
Sold on a plan indirect
12,837
$69.74
$895.25K
BELANOFF JOSEPH K
1 May 2026
Chief Executive Officer
Sold on a plan indirect
40,000
$50.10
$2.00M
BELANOFF JOSEPH K
25 Mar 2026
Chief Executive Officer
Sold on a plan indirect
26,198
$50.07
$1.31M
BELANOFF JOSEPH K
1 Dec 2025
Chief Executive Officer
Sold on a plan indirect
40,000
$79.77
$3.19M
BELANOFF JOSEPH K
5 Nov 2025
Chief Executive Officer
Sold on a plan indirect
3,590
$75.98
$272.76K
BELANOFF JOSEPH K
5 Nov 2025
Chief Executive Officer
Sold on a plan indirect
10,837
$75.14
$814.26K
BELANOFF JOSEPH K
5 Nov 2025
Chief Executive Officer
Sold on a plan indirect
14,355
$74.20
$1.07M
BELANOFF JOSEPH K
3 Nov 2025
Chief Executive Officer
Sold on a plan indirect
11,218
$74.08
$831.01K
BELANOFF JOSEPH K
1 Oct 2025
Chief Executive Officer
Sold on a plan indirect
3,194
$85.67
$273.62K
BELANOFF JOSEPH K
1 Oct 2025
Chief Executive Officer
Sold on a plan indirect
31,190
$85.16
$2.66M
BELANOFF JOSEPH K
1 Oct 2025
Chief Executive Officer
Sold on a plan indirect
5,616
$84.29
$473.37K

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 76
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 5,618,692
History held since 9 Nov 2016